Prof. Tomris Ozben

Department of Clinical Biochemistry

Akdeniz University, Turkey




1993 Ph.D., Ege University, Turkey

1975 B.Sc., American Robert College (Bogazici University), Turkey


  1. OZBEN S, OZBEN B, TANRIKULU AM, OZER F, OZBEN T. Aspirin resistance in patients with acute ischemic stroke. J Neurol.2011 Apr 21.
  2. TANRIKULU, A. M., OZBEN, B., KOC, M., PAPILA-TOPAL, N., OZBEN, T., CAYMAZ, O. Aspirin resistance in patients with chronic renal failure. J Nephrol. 2485):636-646, 2011.
  3. BELLEI E, MONARI E, BERGAMINI S, OZBEN T, TOMASI A. Optimizing protein recovery yield from serum samples treated with beads technology. Electrophoresis. 2011 Jun;32(12):1414-21, 2011.
  4. BELLEI, E., BERGAMINI, S., MONARI, E., FANTONI, L. I., CUOGHI, A., OZBEN, T. TOMASI, A. High-abundance proteins depletion for serum proteomic analysis: concomitant removal of non-targeted proteins. Amino Acids. Jan;40(1):145-56, 2011.
  5. OZBEN B, TANRIKULU AM, OZBEN T, CAYMAZ O. Aspirin resistance in hypertensive patients. J Clin Hypertens.Sep;12(9):714-20, 2010.
  6. DURSUN, E., MONARI, E., CUOGHI, A., BERGAMINI, S., OZBEN, B., SULEYMANLAR, G., TOMASI, A. AND OZBEN, T. "Proteomic profiling during atherosclerosis progression using SELDI-TOF-MS: Effect of darbepoetin treatment", Acta Histochem, 112: 432-443, 2010.
  7. DURSUN, E., OZBEN, B., MONARI, E., CUOGHI, A., TOMASI, A. AND OZBEN, T. "Proteomic profiling in apolipoprotein E-deficient mice during atherosclerosis progression", Acta Histochem, 112(2): 178-188, 2010.
  8. VARAN HI, DURSUN B, DURSUN E, OZBEN T, SULEYMANLAR G. Acute effects of hemodialysis on oxidative stress parameters in chronic uremic patients: comparison of two dialysis membranes. Int J Nephrol Renovasc Dis. 2010;3:39-45.
  9. OZBEN, B., DURSUN, E., MONARI, E., CUOGHI, A., BERGAMINI, S., TOMASI, A. AND OZBEN, T. "Proteomic profiling during atherosclerosis progression: Effect of nebivolol treatment", Mol Cell Biochem, 331, 9-17, 2009.
  10. SAPAN, M., OZBEN, B., YAKUPOGLU, G., SULEYMANLAR, G. AND OZBEN, T. "Effects of diet and gemfibrozil on posttransplant hyperlipidemia in renal transplant recipients", J Investig Med, 57, 456-459, 2009.
  11. DURSUN, B., DURSUN, E., SULEYMANLAR, G., OZBEN, B., CAPRAZ, I., APAYDIN, A. AND OZBEN, T. "The effect of hemodialysis on accelerated atherosclerosis in diabetic patients: correlation of carotid artery intima-media thickness with oxidative stress", J Diabetes Complications, 23, 257-264, 2009.
  12. DURSUN, B., DURSUN, E., CAPRAZ, I., OZBEN, T., APAYDIN, A. AND SULEYMANLAR, G. "Are uremia, diabetes, and atherosclerosis linked with impaired antioxidant mechanisms?" J Investig Med, 56, 545-552, 2008.
  13. DURSUN B, DURSUN E, SULEYMANLAR G, OZBEN B, CAPRAZ I, APAYDIN A, OZBEN T. Carotid Artery Intima-media Thickness Correlates with Oxidative Stress in Chronic Haemodialysis Patients with Accelerated Atherosclerosis. Nephrology Dialysis Transplantation 23(5): 1697-1703,2008.
  14. OZBEN T. Oxidative stress and apoptosis: impact on cancer therapy. Journal of Pharmaceutical Sciences 96(9):2181-2196, 2007.
  15. OZBEN T. Concurrent use of antioxidants in cancer therapy: An update. Expert Review of Clinical Immunology 2(6):931-939, 2006.
  16. OZBEN T. Mechanisms and strategies to overcome multiple drug resistance in cancer. FEBS Letters 580: 2903-2909, 2006.
  17. YILDIZ M, CELIK-OZENCI C, AKAN S, AKAN I, SATI L, DEMİR R, SAVAS B, OZBEN T, SAMUR M, OZDOGAN M, ARTAC M, BOZCUK H. Zoledronic acid is synergic with vinblastine to induce apoptosis in a multidrug resistance protein-1 dependent way: An in vitro study. Cell Biology International Volume 30, Issue 3, March 2006, Pages 278-282.
  18. TIMUR M, AKBAS SH, OZBEN T. The effect of Topotecan on oxidative stress in MCF-7 human breast cancer cell line. Acta Biochimica Polonica 2005;52(4):897-902.
  19. DURSUN E, DURSUN B, SULEYMANLAR G, OZBEN T. Effect of haemodialysis on the oxidative stress and antioxidants in diabetes mellitus. Acta Diabetologica 2005 Oct;42(3):123-8.
  20. OZBEN T, BALKAN E, BALKAN S, SERTESER M, GUMUSLU S. Effects of MK-801 on nitrite and cGMP levels during focal cerebral ischemia in rats. Nitric Oxide. 2005 Nov;13(3):210-5.